MGLCX
Price
$16.74
Change
+$0.20 (+1.21%)
Updated
Sep 8 closing price
Net Assets
2.23B
NRFYX
Price
$11.54
Change
+$0.02 (+0.17%)
Updated
Sep 8 closing price
Net Assets
35.65M
Interact to see
Advertisement

MGLCX vs NRFYX

Header iconMGLCX vs NRFYX Comparison
Open Charts MGLCX vs NRFYXBanner chart's image
MFS Global Real Estate C
Price$16.74
Change+$0.20 (+1.21%)
VolumeN/A
Net Assets2.23B
Natixis AEW Global Focused Real Estate Y
Price$11.54
Change+$0.02 (+0.17%)
VolumeN/A
Net Assets35.65M
MGLCX vs NRFYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MGLCX vs. NRFYX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLCX is a Buy and NRFYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLCX has more cash in the bank: 2.23B vs. NRFYX (35.6M). NRFYX pays higher dividends than MGLCX: NRFYX (3.04) vs MGLCX (1.28). MGLCX was incepted earlier than NRFYX: MGLCX (11 years) vs NRFYX (25 years). MGLCX (1.95) is less costly to investors than NRFYX (1.76). NRFYX is a more actively managed with annual turnover of: 81.00 vs. MGLCX (48.00). MGLCX has a lower initial minimum investment than NRFYX: MGLCX (1000) vs NRFYX (100000). NRFYX annual gain was more profitable for investors over the last year : 0.95 vs. MGLCX (-4.65). NRFYX return over 5 years is better than : 22.24 vs. MGLCX (4.34).
MGLCXNRFYXMGLCX / NRFYX
Total Expense Ratio1.940.90216%
Annual Report Gross Expense Ratio1.951.76111%
Fund Existence11 years25 years-
Gain YTD4.0378.05250%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets2.23B35.6M6,270%
Annual Yield % from dividends1.283.0442%
Returns for 1 year-4.650.95-491%
Returns for 3 years-1.4817.81-8%
Returns for 5 years4.3422.2420%
Returns for 10 years19.32-1.67-1,156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPMY11.480.18
+1.59%
Astellas Pharma, Inc.
VGMIF0.06N/A
N/A
Visible Gold Mines, Inc.
XVIPF20.54N/A
N/A
Xvivo Perfusion AB
FGFI19.10N/A
N/A
First Greenwich Financial Inc.
KWPCF25.50N/A
N/A
Kewpie Corp